Streetbeat News

Analyst Ratings

STRO

JMP Securities analyst Reni Benjamin reiterated a Market Outperform rating on Sutro Biopharma (NASDAQ:STRO) and maintained a $17 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 11:51 am

SNOW

JMP Securities analyst Joe Goodwin reiterated a Market Outperform rating on Snowflake (NYSE:SNOW) and maintained a $200 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 11:50 am

MITT

JMP Securities analyst Trevor Cranston has reiterated a Market Outperform rating on AG Mortgage IT (NYSE:MITT) and maintained a $7 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 11:49 am

ACET

Adicet Bio Inc (NASDAQ:ACET) reported safety and efficacy data from its Phase 1 study of ADI-001 for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma (NHL). The trial showed a 71% overall response rate and 63% complete response rate across all dose levels. JMP Securities downgraded Adicet Bio to Market Perform from Market Outperform rating. The company plans to progress the ADI-001 program into a potential pivotal Phase 2 study in post-CAR T large B-cell lymphoma in the first half of 2024.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 11:49 am

REGN

RBC Capital analyst Brian Abrahams reiterates a Sector Perform rating on Regeneron Pharmaceuticals (NASDAQ:REGN) and maintains an $816 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 11:45 am

NCR

RBC Capital analyst Daniel Perlin has reiterated an Outperform rating on NCR (NYSE:NCR) and maintained a $32 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 11:44 am

AGIO

RBC Capital analyst Kennen MacKay maintains an Outperform rating on Agios Pharmaceuticals (NASDAQ:AGIO) and raises the price target from $40 to $42.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 11:43 am

AVTX

RBC Capital analyst Gregory Renza downgrades Avalo Therapeutics (NASDAQ:AVTX) from Outperform to Sector Perform and lowers the price target from $9 to $0.75.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 11:42 am

FTAI

Benchmark analyst Josh Sullivan reiterated a Buy rating on FTAI Aviation (NASDAQ:FTAI) and maintained a $45 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 11:39 am

JBHT

Benchmark analyst Christopher Kuhn reiterates a Buy rating on JB Hunt Transport Servs (NASDAQ:JBHT) and maintains a $195 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 11:37 am